Drug Store Directory Blog
Thursday, September 28, 2006
  Reporters Find MD's Failure to Discuss Side Effects
 
Reporters for Just Say ‘Know’ to Prescription Drugs Initiative Find MD’s Failure to Discuss Side Effects ‘Significantly Higher’ Than New Study Stated

UCLA head researcher says, “We were very liberal.” Actual percentage of physicians who fail to discuss risks of prescribed medication are “much higher” than 65 percent reported on Monday.

New York, NY (PRWEB) September 28, 2006 -- Today, the Just Say “Know” to Prescription Drugs Campaign, aimed at getting one million people to stop and reevaluate the medications they are taking, reported that the percentage of physicians who failed to explain the potential adverse effects of the medications prescribed to patients was significantly higher than the 65 percent reported in an independent study earlier this week. The study conducted by researchers at the David Geffen School of Medicine, University of California, Los Angeles, concluded that when initiating new medications, physicians often fail to communicate critical elements of medication use. But today, Derjung M. Tarn, MD, head researcher for the study, told reporters from the “Just Say Know” initiative that the numbers were “significantly” understated. The disparity results from the methodology applied. According to Dr. Tarn, “We were very liberal.” Dr Tarn told the team covering the story that “if the doctor even said, you won’t experience any side affects from the medication, we counted that as a briefing. Otherwise the percentage would have been much higher.”

“These independent findings confirm the concerns that drive this campaign,” said Dr. Laurence Simon, psychologist, co-founder of the Just Say “Know” to Prescription Drugs Campaign and one of the reporters who interviewed Dr. Tarn. “We’re concerned with the findings, but we’re even more concerned that the study was not more broadly and prominently covered in the media,” said Simon.

Dr. Tarn indicated that researchers did not specifically measure how often physicians discussed non-drug alternatives. When asked if they found any significant evidence that non-drug alternatives are being routinely considered or discussed, Dr. Tarn indicated that it wasn’t enough for her to remember. When asked about the Just Say “Know” Campaign Dr. Tarn said, "I just found out about it this morning, but I think it’s a good idea.”

“This report makes it clear why we need to reach one million people, one million parents and get them to take our form to their healthcare providers,” said Dr. Greg Tefft. “The system is fundamentally broken.”

During the month of October, the initiative aims to get one million parents to take a second look at the prescription medications they are giving their children. Parents will be encouraged to download a form that allows them to thoughtfully evaluate the drugs they are consenting to give to their child. The form collects specific information from their prescribing physician, pharmacist or healthcare provider and requests the provider’s signature attesting that they have fully informed the parent of the risks and benefits of the prescribed medication, as well as non-drug alternatives.

The campaign has declared October Just Say “Know” to Prescription Drugs Month and has scheduled a conference in Washington, D.C. on October 7th to officially launch the campaign.

Organizations and individuals who want to participate in the campaign may go to any of the following websites, look for the Just Say “Know” to Prescription Drugs logo, and download the sheet titled "Take This Form and Sign It." Instructions will be provided on each form.

Psych Truth.Org
Laurence Simon Ph.D.
www.psychtruth.org/justsayknow.htm

MESICS Fitness
Jim Manganiello, Ed.D.
http://www.mesicsfitness.com/jsn-news.htm

For more information email us, call 212-861-7400 or visit www.psychtruth.org/justsayknow.htm
http://www.icspp.org

Contact:
Dr. Dominick Riccio
Phone: 212-861-7400

# # #

Press Contact: Dr. Dominick Riccio
Company Name: Just Say Know Initiative
Email: email protected from spam bots
Phone: 212-861-7400
Website:
www.psychtruth.org/justsayknow.htm

 
Monday, September 25, 2006
  Discount Pharmacy Saves Money for Patients and Families
 
MedSave Discount Pharmacy Lower in Prices Than “Blog Box” Four Dollar Option

As one big box retailer announces lowering their pricing on 100+ generic drugs over the next few months, MedSave Discount Pharmacy has been offering lower generic prices on over 2000 generic drugs for years. Hundreds of those medications are well under 4 dollars per month. In reading the latest “Big Box” quotes he states that they are also doing this for their employees in offering better benefits.

(PRWEB) September 25, 2006 -- As one big box retailer announces lowering their pricing on 100+ generic drugs over the next few months, MedSave Discount Pharmacy has been offering lower generic prices on over 2000 generic drugs for years. Hundreds of those medications are well under 4 dollars per month. In reading the latest “Big Box” quotes he states that they are also doing this for their employees in offering better benefits. Sean Kacsir states that many of the “big box” employees should go to MedSave Discount Pharmacy so they can save on all their medications not just a selected few generics. MedSave Discount Pharmacy operates with an everyday low price leader philosophy and does not work with sales gimmicks to boost sales. Besides if the money one saves, goes towards an overpriced medication not on the list, people really do not come out ahead.

“Since MedSave was founded our business model has always been to offer the lowest prices on our generic drugs. That’s why we have been endorsed by many organizations, like the Minnesota Senior Federation, Coalition of Wisconsin Aging Groups and the United Senior Action Group from Indiana, said Sean Kacsir President of MedSave Inc.

MedSave is also the preferred pharmacy of HSA Clearing Corp, through their HSA Rx Drug Card program. Now people with Health Savings Accounts/HSA, Flex or Cafeteria Plans can not only save more on their prescriptions costs, they can also have the payment taken right out of their Tax-Free accounts for easy verification of their qualified health care expense.

MedSave offers the best prices and provides customers with excellent service, just as they would expect in their local, independent pharmacy. It is a simple concept with no limitations such as age, income or monthly membership fees.

By eliminating costly relationships with insurance companies and stocking primarily lower-cost generics, we have the ability to minimize expenses, allowing us to give discounts as high as 70% off what you may pay in your local pharmacy. In many cases, MedSave Discount Pharmacy pricing may be lower than your current insurance co-pay.

MedSave offers on-site pharmacists who are available by phone or e-mail to answer your questions or address health care concerns. We can provide price quotes over the phone, and help you find a generic substitute for further savings. Our staff is trained to help you find the best ways to reduce your prescription costs. MedSave will also mail directly to your home so you do not need to be close to the store to take part in our everyday low prices.

For a free consultation call 1-866-856-9633 and to save $5 off your first prescription say “HSA" when you call. Visit their website at www.medsaveinc.com

About MedSave Inc.
MedSave Inc. has been a licensed pharmacy in the State of Minnesota since February 18th 2004. If you have questions or would like additional information about MedSave Discount Pharmacy, you may contact the Sean Kacsir at 763-300-7155 or visit their website at www.medsaveinc.com

###

Press Contact: Sean Kacsir
Company Name: MEDSAVE DISCOUNT PHARMACY
Email: email protected from spam bots
Phone: 763-300-7155
Website:
www.medsaveinc.com

 
Sunday, September 24, 2006
  Drug-Free Method for Depression
 
New Drug-Free Method for Depression Often Works When Nothing Else Will

A quiet revolution is underway in the treatment of depression, guilt, anger, and other destructive emotions. Instead of drugs or psychoanalysis, psychologists and counselors are using Emotional Freedom Techniques, or EFT, which combines focused thought with fingertip tapping on key acupressure points. They claim a high success rate with lasting results.

San Francisco, CA (PRWEB) September 24, 2006 -- Depression is one of the most difficult and expensive conditions affecting Americans today. Despite a century of medical research, no one has found a treatment that works – and the number of patients affected by depression continues to increase.

But a growing number of psychologists, medical doctors, and other health care practitioners say that a simple do-it-yourself acupressure tapping technique called EFT (Emotional Freedom Techniques) can alleviate depression and other destructive emotions within minutes, with lasting results. The procedure is described in a free manual available from http://www.emofree.com/downloadeftmanual.asp?ref=prwdepressioncj

Psychiatrists used to approach depression and other emotional conditions with talk therapy, but discussing the past seldom brought relief. Today’s psychiatrists use psychoactive drugs to treat brain chemistry imbalances. While this approach may suppress symptoms, it doesn’t address the condition’s underlying causes, and when drugs are discontinued, symptoms recur.

Fred Gallo, PhD., a Pittsburgh-area psychologist and editor of the book Energy Psychology in Psychotherapy, has patients focus on unhappy events, but at the same time he has them gently tap on EFT’s key acupuncture points.

“Using EFT,” he says, “I have successfully treated fears, phobias, depression, trauma, and addictions. Its effects are rapid, dramatic, and deep.”

Since developing EFT fifteen years ago, Stanford-trained engineer Gary Craig has trained thousands of health care professionals.

“Depression responds very well to EFT,” he says. “In most cases the depressed feelings vanish or are materially reduced within a few minutes of applying it. No drugs are involved. Also, repeated applications of EFT often eliminate these feelings permanently so that they no longer reappear on a daily, weekly or monthly basis."

According to Craig, most EFT practitioners report an 80-percent success rate in treating depression and other unresolved emotional issues. Its basic premise is that the underlying cause of all negative emotions, including depression, is an energy block in one or more of the body’s meridians, the same energy pathways mapped thousands of years ago by Chinese physicians.

“The combination of tapping and mental focus releases the energy blocks,” he explains, “and the symptoms they cause are released at the same time.”

EFT is a new procedure, but already more than 300,000 – including thousands of health care practitioners – have downloaded its free manual from
http://www.emofree.com/downloadeftmanual.asp?ref=prwdepressioncj
and an additional 10,000 download it every month. The manual is available in nine languages, and EFT practitioners around the world, especially in the U.S., Canada, Europe, Japan, and Australia, teach EFT classes and work with clients.

For additional information, contact Gary Craig at 707-785-2848.

###

Press Contact: Gary Craig
Company Name: EFT
Email: email protected from spam bots
Phone: 707-785 2848
Website:
http://www.emofree.com?ref=prwdepressioncj

 
Friday, September 15, 2006
  Report On Prescribing Data Restriction Program (PDRP) Available
 
Prescribing Data Restriction Program (PDRP) Report Available from Piribo

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on the Prescribing Data Restriction Program.

(PRWEB) September 15, 2006 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on the Prescribing Data Restriction Program.

Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. However, with the introduction of the AMA's Prescribing Data Restriction Program (PDRP) opt-out program in July 2006, pharma companies need to evaluate the impact of PDRP violation, mediate their PDRP compliance strategies, and revisit their existing Sales Force Effectiveness (SFE) practices. With the introduction of the PDRP, the use of physician Rx data by pharmaceutical companies will never be the same again. The PDRP prohibits access to physician-level Rx data, which directly impacts First Line Managers, Sales Representatives, and anyone else that accesses or distributes physician Rx data.

The Prescribing Data Restriction Program: Critical Assessment and Best Practices (http://www.piribo.com/search/results.html?k=arr014&x=0&y=0) estimates the impact of PDRP violations, analyzes the use of Rx data, gauges awareness in the marketplace and benchmarks the best practices towards PDRP compliance.

Table of Contents:
Objective and Methodology
Methodology
Abbreviations
Key takeaways

1 Executive Summary
1.1 Mixed responses towards compliance
1.2 PDRP impacts all pharma companies
1.3 Critical success factor
1.4 Best practice of pharma companies’ PDRP compliance strategies - mix of standard operating practices and
technology

2 Introduction
2.1 PDRP definition from AMA
2.2 About the PDRP and need to adopt best practices
2.3 Very low awareness of the PDRP
2.4 Impact of Sales Rep's and DM's lack of access to Rx data
2.5 Finding the right balance in implementing PDRP compliance strategies
2.6 There are currently no recommended best practices for PDRP compliance
2.7 Legislators observing PDRP compliance closely
2.8 Compelling reasons for pharma companies to comply with the PDRP
2.8.1 Avoiding negative publicity is key motive for PDRP compliance
2.8.2 Loss of Rx data

3 Impact of the PDRP on pharma companies
3.1 Pharma companies underestimate the impact of the PDRP
3.2 All pharma companies will be impacted by the PDRP
3.3 PDRP can increase sales and marketing costs by 20%
3.4 Risk of ineffectiveness in the sales force in absence of Rx data - highest loss component
3.5 Impact of the PDRP on competitive edge

4 Critical success factors for complying with the PDRP
4.1 Use and blocking of Rx data
4.2 The issue of reverse engineering
4.3 Changes in technology and systems are a must to comply with the PDRP
4.4 Technology solution
4.5 Existing SFE strategies
4.6 Time and cost of implementation
4.7 Balancing PDRP compliance and the need for a competitive edge
4.8 Defense strategy
4.9 Issues and challenges
5 Best practices towards PDRP compliance
5.1 Best standard operating practices by pharma companies
5.1.1 SFE planning and execution
5.1.2 SFE planning department - senior managers not interacting with physicians
5.1.3 SFE planning department to perform targeting and segmentation
5.1.4 SFE execution department - Sales Rep and DM
5.1.5 Benefits of the above model
5.2 Incentive structure
5.2.1 Option 1
5.2.2 Option 2
5.2.3 Option 3
5.3 Pull-through strategies
5.4 Important parameters to determine the top prescribing physicians within the influential plans
5.4.1 A few more SOPs towards PDRP compliance
5.5 Sales Reps, DMs and PDRP compliance
5.5.1 Training of Sales Reps
5.5.2 Sales Reps' use of Rx data
5.5.3 Sales Reps and the reverse engineering of data
5.5.4 Sales Reps understanding of the "Big Picture"
5.5.5 Sales Rep employee contracts: Redefined?
5.5.6 Sales Reps and market intelligence
5.6 Technology priorities to comply with the PDRP
5.6.1 SFA/CRM systems
5.6.2 Security of reports
5.6.3 Rx details in incentive slips
5.6.4 New technology solutions?
5.6.5 Apt PDRP compliance strategies pay off
5.6.6 Pharma companies' perceptions of cost of PDRP compliance
5.6.7 Time allowance for PDRP compliance
5.8 Foolproof defense strategies
6 Conclusions: Roadmap to PDRP compliance
6.1 Best Practices
6.2.1 SFE planning and SFE execution
6.2.2 New use of target lists
6.2.3 "Pre-calling", "During calls" and "Post calls"
6.2.4 Sales Rep training
6.2.5 Incentive calculations
6.2.6 SFE/CRM technology solutions

“The Prescribing Data Restriction Program - Critical Assessment and Best Practices” is available in PDF format from Piribo. For more information, go to: http://www.piribo.com/publications/regulation_policy/prescribing_data_
 
 
restriction_programcritical_assessment_practices.html

About Piribo
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Press Contact: Brendt Sheen
Company Name: PIRIBO LTD
Email: email protected from spam bots
Phone: 02070607474
Website:
http://www.piribo.com/publications/regulation_policy/prescribing_data_restriction_programcritical_as

 
Covers news and information on drug stores, pharmacies, Internet pharmacies, pharmaceutical industry, drug research, offshore drug stores, and related drug and pharmacy information.




ARCHIVES
August 2005 / September 2005 / October 2005 / November 2005 / December 2005 / January 2006 / February 2006 / March 2006 / April 2006 / May 2006 / June 2006 / July 2006 / August 2006 / September 2006 / October 2006 / November 2006 / December 2006 / January 2007 / February 2007 / March 2007 / April 2007 / May 2007 / June 2007 / July 2007 / August 2007 / September 2007 / October 2007 / November 2007 / December 2007 / January 2008 / February 2008 / March 2008 /



Powered by Blogger

medicine | pharmacy | drug store | drugs